-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of the cost of borrowed funds accounted for as interest expense.
-
Summary
-
Coeptis Therapeutics Holdings, Inc. quarterly/annual Interest Expense history and growth rate from 2022 to 2024.
- Coeptis Therapeutics Holdings, Inc. Interest Expense for the quarter ending March 31, 2024 was $201 K, a 538% increase year-over-year.
- Coeptis Therapeutics Holdings, Inc. Interest Expense for the twelve months ending March 31, 2024 was $277 K, a 42.7% increase year-over-year.
- Coeptis Therapeutics Holdings, Inc. annual Interest Expense for 2023 was $108 K, a 50.7% decline from 2022.
- Coeptis Therapeutics Holdings, Inc. annual Interest Expense for 2022 was $218 K, a 16.7% increase from 2021.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)